Form 8-K - Current report:
SEC Accession No. 0001437749-25-016832
Filing Date
2025-05-14
Accepted
2025-05-14 16:06:01
Documents
17
Period of Report
2025-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aytu20250213_8k.htm   iXBRL 8-K 28950
2 EXHIBIT 99.1 ex_778276.htm EX-99.1 280725
7 logo01.jpg GRAPHIC 3651
8 logo.jpg GRAPHIC 4381
  Complete submission text file 0001437749-25-016832.txt   488421

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aytu-20250514.xsd EX-101.SCH 3580
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20250514_def.xml EX-101.DEF 11808
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20250514_lab.xml EX-101.LAB 15859
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20250514_pre.xml EX-101.PRE 12023
19 EXTRACTED XBRL INSTANCE DOCUMENT aytu20250213_8k_htm.xml XML 2947
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 25945361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)